23andMe founder Anne Wojcicki wants to take the company private

The company has cut staff, faced stock delisting, lost a key drug-developing collaboration and been hit by hackers in the past year.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks